Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$5.66 - $7.59 $436,804 - $585,750
-77,174 Reduced 62.61%
46,090 $297,000
Q1 2023

May 15, 2023

BUY
$7.31 - $11.18 $52,354 - $80,071
7,162 Added 6.17%
123,264 $929,000
Q4 2022

Feb 14, 2023

BUY
$9.48 - $14.52 $355,158 - $543,977
37,464 Added 47.64%
116,102 $1.18 Million
Q3 2022

Nov 14, 2022

BUY
$9.2 - $13.68 $723,469 - $1.08 Million
78,638 New
78,638 $778,000
Q1 2022

May 16, 2022

SELL
$7.46 - $14.14 $211,975 - $401,788
-28,415 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$12.99 - $17.73 $580,029 - $791,679
-44,652 Reduced 61.11%
28,415 $406,000
Q3 2021

Nov 15, 2021

BUY
$14.85 - $21.34 $706,548 - $1.02 Million
47,579 Added 186.67%
73,067 $1.46 Million
Q2 2021

Aug 16, 2021

BUY
$20.19 - $34.17 $514,602 - $870,924
25,488 New
25,488 $561,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $807M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.